Clinical Trial Update: Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial at New York Medical College evaluating vorinostat in combination with chemotherapy for relapsed/refractory solid tumors and CNS malignancies; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Germ Cell Tumor
• Hepatoblastoma
• Neuroblastoma
• Rhabdomyosarcoma
• Wilms Tumor

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: New York Medical College | Conditions: Ewing Sarcoma, Rhabdomyosarcoma | Phase 1 | Status: RECRUITING